Seelos Therapeutics, Inc. Common Stock
SEEL
SEEL was delisted on the 15th of October, 2024.
3 hedge funds and large institutions have $14.5M invested in Seelos Therapeutics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
14% more call options, than puts
Call options by funds: $146K | Put options by funds: $128K
0% more funds holding
Funds holding: 3 → 3 (0)
13% less capital invested
Capital invested by funds: $16.6M → $14.5M (-$2.12M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$91K |
| 2 |
Goldman Sachs
New York
|
-$59K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$32K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ST
26
Sphinx Trading
Chicago,
Illinois
| $2K | – | – | – |
|
27
Citigroup
New York
| $1K | – | – | – |
|
|
HDIM
28
Hanson & Doremus Investment Management
Burlington,
Vermont
| $1K | – | – | – |
|
|
LTFS
29
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
30
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $6 | – | – | – |
|
|
BIP
31
Brandes Investment Partners
La Jolla,
California
| – | -$91K | – | – |
|
|
32
Goldman Sachs
New York
| – | -$59K | – | – |
|
|
33
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$32K | – | – |
|
SEEL Hedge Fund Activity: Q3 2015 in Review
3 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q3 2015, worth a combined $14.5M — down 13% from $16.6M a quarter earlier.
Fund positioning in SEEL was balanced in Q3 2015: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was Brandes Investment Partners, cutting an estimated $91K.
- 3 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q3 2015, unchanged from Q2 2015.
- Funds reported $14.5M of Seelos Therapeutics, Inc. Common Stock stock for Q3 2015, down 13% quarter-over-quarter.
- 0 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q3 2015 and 0 closed out.
- The largest Seelos Therapeutics, Inc. Common Stock seller in Q3 2015 was Brandes Investment Partners, an estimated $91K sold.
Based on aggregated 13F filings for Q3 2015.